ÂÜÀòÂÒÂ×

Tucker Kelly is Executive Vice President, Chief Financial Officer and Treasurer of Deciphera Pharmaceuticals. Mr. Kelly joined Deciphera in 2015 and has more than 20 years of experience in the life sciences industry as a Chief Financial Officer, investment banker, and lawyer. Before joining Deciphera, Mr. Kelly served as Chief Financial Officer of various public and private life sciences companies including AdvanDx, Inc., deCODE genetics, Inc., and Critical Therapeutics, Inc. Prior to becoming a chief financial officer, Mr. Kelly was a life sciences investment banker at Robertson Stephens and Canaccord Adams and earlier in his career was an attorney in the corporate and securities group of Foley, Hoag and Elliot, LLP. Mr. Kelly received a B.S. in Foreign Services cum laude from the Georgetown University School of Foreign Service and a J.D. with honors from the University of Chicago Law School.